| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TherapeuticsMD, Inc. | Chief Executive Officer | Common Stock | 73,639 | $73,529 | $0.9985 | 14 Apr 2025 | Direct |
| TherapeuticsMD, Inc. | Chief Executive Officer | Restricted Stock Units | 1,733 | $3,005 | $1.73 | 18 Feb 2025 | Direct |
| TherapeuticsMD, Inc. | Chief Executive Officer | Performance Stock Units | 0 | $0 | $1.73 | 18 Feb 2025 | Direct |
| TherapeuticsMD, Inc. | Chief Executive Officer | Non-Qualified Stock Option (right to buy) | 67,492 | 03 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TXMD | TherapeuticsMD, Inc. | 03 Nov 2025 | 1 | $0 | 4 | Chief Executive Officer | 05 Nov 2025, 16:16 |
| TXMD | TherapeuticsMD, Inc. | 14 Apr 2025 | 1 | +$489 | 4 | Chief Executive Officer | 15 Apr 2025, 07:59 |
| TXMD | TherapeuticsMD, Inc. | 09 Apr 2025 | 2 | +$1,994 | 4 | Chief Executive Officer | 10 Apr 2025, 16:29 |
| TXMD | TherapeuticsMD, Inc. | 18 Feb 2025 | 8 | $0 | 4 | Chief Executive Officer | 20 Feb 2025, 21:07 |
| TXMD | TherapeuticsMD, Inc. | 05 Dec 2023 | 4 | -$43,684 | 4 | Chief Executive Officer | 07 Dec 2023, 16:51 |
| TXMD | TherapeuticsMD, Inc. | 12 Apr 2023 | 5 | -$2,518 | 4/A | Chief Executive Officer | 04 May 2023, 16:38 |
| TXMD | TherapeuticsMD, Inc. | 21 Feb 2023 | 1 | $0 | 4 | Chief Executive Officer | 23 Feb 2023, 16:16 |
| TXMD | TherapeuticsMD, Inc. | 31 Dec 2022 | 1 | $0 | 5 | Chief Executive Officer | 13 Feb 2023, 16:23 |
| TXMD | TherapeuticsMD, Inc. | 06 Dec 2022 | 7 | -$5,185 | 4 | General Counsel | 09 Dec 2022, 18:38 |
| TXMD | TherapeuticsMD, Inc. | 31 Mar 2022 | 1 | $0 | 4 | General Counsel | 31 Mar 2022, 17:16 |
| TXMD | TherapeuticsMD, Inc. | 23 Mar 2022 | 1 | $0 | 4 | General Counsel | 28 Mar 2022, 07:00 |
| TXMD | TherapeuticsMD, Inc. | 23 Mar 2022 | 1 | $0 | 4 | General Counsel | 28 Mar 2022, 07:00 |
| TXMD | TherapeuticsMD, Inc. | 14 Mar 2022 | 2 | $0 | 4 | General Counsel | 15 Mar 2022, 07:00 |
| TXMD | TherapeuticsMD, Inc. | 29 Sep 2021 | 5 | $0 | 4 | General Counsel | 01 Oct 2021, 17:00 |
| TXMD | TherapeuticsMD, Inc. | 01 Jul 2021 | 2 | $0 | 4 | General Counsel | 02 Jul 2021, 17:48 |
| TXMD | TherapeuticsMD, Inc. | 10 May 2021 | 3 | -$22,456 | 4 | General Counsel | 12 May 2021, 20:43 |